Search results (10)
« Back to PublicationsHuman induced pluripotent stem cell-derived cardiac myocytes and sympathetic neurons in disease modelling.
Journal article
Li N. et al, (2023), Philos Trans R Soc Lond B Biol Sci, 378
Abnormal Cyclic Nucleotide Signaling at the Outer Mitochondrial Membrane In Sympathetic Neurons During the Early Stages of Hypertension.
Journal article
Li D. et al, (2022), Hypertension, 79, 1374 - 1384
Molecular Correlates of Early Onset of Diabetic Cardiomyopathy: Possible Therapeutic Targets.
Journal article
Wang D. et al, (2022), Oxid Med Cell Longev, 2022
Healthy cardiac myocytes can decrease sympathetic hyperexcitability in the early stages of hypertension.
Journal article
Davis H. et al, (2022), Front Synaptic Neurosci, 14
The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
Journal article
Kalla M. et al, (2020), Eur Heart J, 41, 2168 - 2179
Coronary Sinus Neuropeptide Y Levels and Adverse Outcomes in Patients With Stable Chronic Heart Failure.
Journal article
Ajijola OA. et al, (2020), JAMA Cardiol, 5, 318 - 325
Phosphodiesterase 2A as a therapeutic target to restore cardiac neurotransmission during sympathetic hyperactivity.
Journal article
Liu K. et al, (2018), JCI Insight, 3
Overexpression of Sarcoendoplasmic Reticulum Calcium ATPase 2a Promotes Cardiac Sympathetic Neurotransmission via Abnormal Endoplasmic Reticulum and Mitochondria Ca2+ Regulation.
Journal article
Shanks J. et al, (2017), Hypertension, 69, 625 - 632
Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons.
Journal article
Li D. et al, (2015), Hypertension, 66, 190 - 198
CAPON modulates neuronal calcium handling and cardiac sympathetic neurotransmission during dysautonomia in hypertension.
Journal article
Lu C-J. et al, (2015), Hypertension, 65, 1288 - 1297

